CERAZETTE

Cerazette Adverse Events Reported to the FDA Over Time

How are Cerazette adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Cerazette, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Cerazette is flagged as the suspect drug causing the adverse event.

Most Common Cerazette Adverse Events Reported to the FDA

What are the most common Cerazette adverse events reported to the FDA?

Amenorrhoea	30 (2.87%)
Menstruation Irregular	25 (2.39%)
Drug Interaction	23 (2.2%)
Pregnancy On Oral Contraceptive	21 (2.01%)
Drug Exposure During Pregnancy	17 (1.62%)
Abortion Spontaneous	16 (1.53%)
Off Label Use	16 (1.53%)
Abdominal Pain	15 (1.43%)
Nausea	15 (1.43%)
Headache	14 (1.34%)
Hypertension	14 (1.34%)
	Show More
Inappropriate Schedule Of Drug Admi...	12 (1.15%)
Pulmonary Embolism	12 (1.15%)
Swelling	12 (1.15%)
Vaginal Haemorrhage	12 (1.15%)
Menorrhagia	11 (1.05%)
Metrorrhagia	11 (1.05%)
Asthenia	10 (.96%)
Breast Swelling	10 (.96%)
Dizziness	10 (.96%)
Hypothyroidism	10 (.96%)
Aggression	9 (.86%)
Depression	9 (.86%)
Ovarian Cyst	9 (.86%)
Vomiting	9 (.86%)
Weight Increased	9 (.86%)
Anaemia	8 (.76%)
Condition Aggravated	8 (.76%)
Drug Dose Omission	8 (.76%)
Oedema Peripheral	8 (.76%)
Weight Decreased	8 (.76%)
Nervousness	7 (.67%)
Pain In Extremity	7 (.67%)
Tinnitus	7 (.67%)
Agitation	6 (.57%)
Burning Sensation	6 (.57%)
Cerebrovascular Accident	6 (.57%)
Epilepsy	6 (.57%)
Insomnia	6 (.57%)
Menstruation Delayed	6 (.57%)
Pain	6 (.57%)
Polycystic Ovaries	6 (.57%)
Pregnancy	6 (.57%)
Tachycardia	6 (.57%)
Anger	5 (.48%)
Appetite Disorder	5 (.48%)
Balance Disorder	5 (.48%)
Breast Pain	5 (.48%)
Chest Pain	5 (.48%)
Diarrhoea	5 (.48%)
Focal Nodular Hyperplasia	5 (.48%)
Hepatic Steatosis	5 (.48%)
Hyperhidrosis	5 (.48%)
Malaise	5 (.48%)
Restlessness	5 (.48%)
Swelling Face	5 (.48%)
Tremor	5 (.48%)
Antepartum Haemorrhage	4 (.38%)
Anxiety	4 (.38%)
Back Pain	4 (.38%)
Caesarean Section	4 (.38%)
Cholelithiasis	4 (.38%)
Deep Vein Thrombosis	4 (.38%)
Drug Ineffective	4 (.38%)
Dysmenorrhoea	4 (.38%)
Eye Disorder	4 (.38%)
Haemorrhage	4 (.38%)
Hypomenorrhoea	4 (.38%)
Influenza	4 (.38%)
Intertrigo	4 (.38%)
Paraesthesia	4 (.38%)
Paralysis	4 (.38%)
Pneumonia	4 (.38%)
Pregnancy With Implant Contraceptiv...	4 (.38%)
Pruritus	4 (.38%)
Pustular Psoriasis	4 (.38%)
Stress At Work	4 (.38%)
Suicidal Ideation	4 (.38%)
Syncope	4 (.38%)
Uterine Disorder	4 (.38%)
Uterine Leiomyoma	4 (.38%)
Vulvovaginal Mycotic Infection	4 (.38%)
White Blood Cell Count Increased	4 (.38%)
Abdominal Distension	3 (.29%)
Asthma	3 (.29%)
Blood Cholesterol Increased	3 (.29%)
Carotid Artery Thrombosis	3 (.29%)
Carpal Tunnel Syndrome	3 (.29%)
Cholestasis	3 (.29%)
Delusion	3 (.29%)
Drug Exposure Via Breast Milk	3 (.29%)
Dysphagia	3 (.29%)
Ectopic Pregnancy	3 (.29%)
Fatigue	3 (.29%)
Feeling Abnormal	3 (.29%)
Hepatic Neoplasm	3 (.29%)
Hepatitis Acute	3 (.29%)
Impaired Work Ability	3 (.29%)
Irritability	3 (.29%)
Loss Of Libido	3 (.29%)
Menstrual Disorder	3 (.29%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Cerazette, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cerazette is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Cerazette

What are the most common Cerazette adverse events reported to the FDA?

Menstrual Cycle And Uterine Bleedin...	101 (9.65%)
Gastrointestinal Signs	53 (5.06%)
Neurological	41 (3.92%)
Pregnancy, Labour, Delivery And Pos...	35 (3.34%)
Therapeutic And Nontherapeutic Effe...	34 (3.25%)
Medication Errors	26 (2.48%)
Anxiety Disorders	24 (2.29%)
Hepatic And Hepatobiliary	24 (2.29%)
Epidermal And Dermal Conditions	23 (2.2%)
Therapeutic Procedures And Supporti...	20 (1.91%)
Chemical Injury And Poisoning	19 (1.81%)
	Show More
Abortions And Stillbirth	18 (1.72%)
Breast	17 (1.62%)
Infections - Pathogen Unspecified	17 (1.62%)
Ovarian And Fallopian Tube	17 (1.62%)
Physical Examination Topics	17 (1.62%)
Vascular Hypertensive	17 (1.62%)
Headaches	16 (1.53%)
Central Nervous System Vascular	15 (1.43%)
Vulvovaginal Disorders	15 (1.43%)
Musculoskeletal And Connective Tiss...	13 (1.24%)
Thyroid Gland	13 (1.24%)
Cardiac Arrhythmias	12 (1.15%)
Mood Disorders	12 (1.15%)
Pulmonary Vascular	12 (1.15%)
Appetite And General Nutritional	11 (1.05%)
Depressed Mood Disorders	11 (1.05%)
Hematology Investigations	11 (1.05%)
Coronary Artery	10 (.96%)
Uterine, Pelvic And Broad Ligament	10 (.96%)
Maternal Complications Of Pregnancy	9 (.86%)
Movement Disorders	9 (.86%)
Personality Disorders	9 (.86%)
Anemias Nonhemolytic And Marrow Dep...	8 (.76%)
Inner Ear And Viiith Cranial Nerve	8 (.76%)
Skin Appendage Conditions	8 (.76%)
Seizures	7 (.67%)
Spleen, Lymphatic And Reticulendoth...	7 (.67%)
Embolism And Thrombosis	6 (.57%)
Eye	6 (.57%)
Gastrointestinal Motility And Defec...	6 (.57%)
Sleep Disorders	6 (.57%)
Viral Infectious	6 (.57%)
Changes In Physical Activity	5 (.48%)
Economic And Housing Issues	5 (.48%)
Gastrointestinal Therapeutic Proced...	5 (.48%)
Hepatic And Biliary Neoplasms Benig...	5 (.48%)
Lifestyle Issues	5 (.48%)
Ocular Neuromuscular	5 (.48%)
Respiratory	5 (.48%)
Sexual Dysfunctions, Disturbances A...	5 (.48%)
Vascular Hemorrhagic	5 (.48%)
Fungal Infectious	4 (.38%)
Gallbladder	4 (.38%)
Gastrointestinal Hemorrhages	4 (.38%)
Hearing	4 (.38%)
Joint	4 (.38%)
Lipid Analyses	4 (.38%)
Muscle	4 (.38%)
Obstetric And Gynecological Therape...	4 (.38%)
Reproductive Neoplasms Female Benig...	4 (.38%)
Somatoform And Factitious	4 (.38%)
Suicidal And Self-injurious Behavio...	4 (.38%)
Arteriosclerosis, Stenosis, Vascula...	3 (.29%)
Bladder And Bladder Neck Disorders	3 (.29%)
Bronchial Disorders	3 (.29%)
Decreased And Nonspecific Blood Pre...	3 (.29%)
Disturbances In Thinking	3 (.29%)
Gastrointestinal Conditions	3 (.29%)
Gastrointestinal Inflammatory Condi...	3 (.29%)
Glucose Metabolism Disorders	3 (.29%)
Hepatobiliary Neoplasms Malignant A...	3 (.29%)
Immunology And Allergy	3 (.29%)
Mental Impairment	3 (.29%)
Peripheral Neuropathies	3 (.29%)
Procedural And Device Related Injur...	3 (.29%)
Soft Tissue Neoplasms Benign	3 (.29%)
Vision	3 (.29%)
Allergic Conditions	2 (.19%)
Bacterial Infectious	2 (.19%)
Electrolyte And Fluid Balance Condi...	2 (.19%)
Endocrine Neoplasms Malignant And U...	2 (.19%)
Exocrine Pancreas Conditions	2 (.19%)
Gastrointestinal Ulceration And Per...	2 (.19%)
Gastrointestinal Vascular Condition...	2 (.19%)
Gender Related Factors	2 (.19%)
Heart Failures	2 (.19%)
Hematological And Lymphoid Tissue T...	2 (.19%)
Hepatobiliary	2 (.19%)
Injuries	2 (.19%)
Malignant And Unspecified Neoplasms...	2 (.19%)
Oral Soft Tissue Conditions	2 (.19%)
Renal And Urinary Tract Investigati...	2 (.19%)
Spinal Cord And Nerve Root	2 (.19%)
Urinary Tract Signs	2 (.19%)
Vascular Inflammations	2 (.19%)
Administration Site Reactions	1 (.1%)
Aneurysms And Artery Dissections	1 (.1%)
Angiedema And Urticaria	1 (.1%)
Aural	1 (.1%)
Body Temperature Conditions	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Cerazette, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cerazette is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.